H. O. Atladottir, P. Thorsen, L. Ostergaard, D. E. Schendel, and S. Lemcke, Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders, J Autism Dev Disord, vol.40, pp.1423-1430, 2010.

A. S. Brown and E. J. Derkits, Prenatal infection and schizophrenia: a review of epidemiologic and translational studies, Am J Psychiatry, vol.167, pp.261-280, 2010.

H. Hagberg, P. Gressens, and C. Mallard, Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults, Ann Neurol, vol.71, pp.444-457, 2012.

P. Boksa, Effects of prenatal infection on brain development and behavior: A review of findings from animal models, Brain Behav Immun, vol.24, pp.881-897, 2010.

M. Baharnoori, W. G. Brake, and L. K. Srivastava, Prenatal immune challenge induces developmental changes in the morphology of pyramidal neurons of the prefrontal cortex and hippocampus in rats, Schizophr Res, vol.107, pp.99-109, 2009.

L. Harvey and P. Boksa, A stereological comparison of GAD67 and reelin expression in the hippocampal stratum oriens of offspring from two mouse models of maternal inflammation during pregnancy, Neuropharmacology, vol.62, pp.1767-1776, 2012.

D. Nouel, M. Burt, Y. Zhang, L. Harvey, and P. Boksa, Prenatal exposure to bacterial endotoxin reduces the number of GAD67-and reelin-immunoreactive neurons in the hippocampus of rat offspring, European Neuropsychopharmacology, vol.22, pp.300-307, 2012.

R. Batista-novais, A. Guiramand, J. Cohen-solal, C. Crouzin, N. De et al., N-acetyl-cysteine prevents pyramidal cell disarray and reelin-immunoreactive neuron deficiency in CA3 after prenatal immune challenge in rats, Pediatr Res, vol.73, pp.750-755, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00809177

J. R. Whitlock, A. J. Heynen, M. G. Shuler, and M. F. Bear, Learning induces longterm potentiation in the hippocampus, Science, vol.313, pp.1093-1097, 2006.

Y. Ge, Z. Dong, R. C. Bagot, J. G. Howland, and A. G. Phillips, Hippocampal long-term depression is required for the consolidation of spatial memory, Proceedings of the National Academy of Sciences of the United States of America, vol.107, pp.16697-16702, 2010.

F. Lante, J. Meunier, J. Guiramand, D. J. Ferreira, M. C. Cambonie et al., Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation, Hippocampus, vol.18, pp.602-609, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00397553

F. Lante, J. Meunier, J. Guiramand, M. T. Cavalier, and M. , Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain, Free Radic Biol Med, vol.42, pp.1231-1245, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00397595

Y. Zhang, B. N. Cazakoff, C. A. Thai, and J. G. Howland, Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats, Neuropharmacology, vol.62, pp.1299-1307, 2012.

S. A. Rana, T. Aavani, and Q. J. Pittman, Sex effects on neurodevelopmental outcomes of innate immune activation during prenatal and neonatal life, Horm Behav, vol.62, pp.228-236, 2012.

M. Escobar, N. Crouzin, M. Cavalier, J. Quentin, and J. Roussel, Early, time-dependent disturbances of hippocampal synaptic transmission and plasticity after in utero immune challenge, Biol Psychiatry, vol.70, pp.992-999, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00574559

O. Donnell and P. , Adolescent onset of cortical disinhibition in schizophrenia: insights from animal models, Schizophr Bull, vol.37, pp.484-492, 2011.

J. E. Belforte, V. Zsiros, E. R. Sklar, Z. Jiang, and G. Yu, Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes, Nat Neurosci, vol.13, pp.76-83, 2010.

G. Paxinos and C. Watson, The rat brain in stereotaxic coordinates, 1998.

L. R. Shao and F. E. Dudek, Both synaptic and intrinsic mechanisms underlie the different properties of population bursts in the hippocampal CA3 area of immature versus adult rats, J Physiol, vol.587, pp.5907-5923, 2009.

G. Gonzalez-burgos, GABA transporter GAT1: a crucial determinant of GABAB receptor activation in cortical circuits, Adv Pharmacol, vol.58, pp.175-204, 2010.

P. C. Waldmeier, K. Kaupmann, and S. Urwyler, Roles of GABAB receptor subtypes in presynaptic auto-and heteroreceptor function regulating GABA and glutamate release, J Neural Transm, vol.115, pp.1401-1411, 2008.

R. A. Pearce, S. D. Grunder, and L. D. Faucher, Different mechanisms for usedependent depression of two GABAA-mediated IPSCs in rat hippocampus, J Physiol, vol.484, issue.2, pp.425-435, 1995.

J. J. Wagner and B. E. Alger, GABAergic and developmental influences on homosynaptic LTD and depotentiation in rat hippocampus, J Neurosci, vol.15, pp.1577-1586, 1995.

F. M. Benes, E. W. Kwok, S. L. Vincent, and M. S. Todtenkopf, A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives, Biological Psychiatry, vol.44, pp.88-97, 1998.

F. M. Benes, B. Lim, D. Matzilevich, J. P. Walsh, and S. Subburaju, Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars, Proc Natl Acad Sci U S A, vol.104, pp.10164-10169, 2007.

M. B. Knable, B. M. Barci, M. J. Webster, J. Meador-woodruff, and E. F. Torrey, Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium, Mol Psychiatry, vol.9, pp.609-620, 2004.

M. S. Todtenkopf and F. M. Benes, Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain, Synapse, vol.29, pp.323-332, 1998.

U. Meyer, M. Nyffeler, B. K. Yee, I. Knuesel, and J. Feldon, Adult brain and behavioral pathological markers of prenatal immune challenge during early/ middle and late fetal development in mice, Brain Behav Immun, vol.22, pp.469-486, 2008.

A. M. Samuelsson, E. Jennische, H. A. Hansson, and A. Holmang, Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning, American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol.290, pp.1345-1356, 2006.

J. Richetto, F. Calabrese, M. A. Riva, and U. Meyer, Prenatal Immune Activation Induces Maturation-Dependent Alterations in the Prefrontal GABAergic Transcriptome, Schizophr Bull, 2013.

R. W. Buchanan, R. S. Keefe, J. A. Lieberman, D. M. Barch, and J. G. Csernansky, A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia, Biol Psychiatry, vol.69, pp.442-449, 2011.

J. R. Atack, Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA, Pharmacol Ther, vol.125, pp.11-26, 2010.

M. Uusi-oukari and E. R. Korpi, Regulation of GABA(A) receptor subunit expression by pharmacological agents, Pharmacol Rev, vol.62, pp.97-135, 2010.

S. M. Dudek and M. F. Bear, Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade, Proc Natl Acad Sci, vol.89, pp.4363-4367, 1992.

R. M. Mulkey and R. C. Malenka, Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus, Neuron, vol.9, pp.967-975, 1992.

G. Cambonie, H. Hirbec, M. Michaud, J. Kamenka, and G. Barbanel, Prenatal infection obliterates glutamate-related protection against free hydroxyl radicals in neonatal rat brain, J Neurosci Res, vol.75, pp.125-132, 2004.

M. J. Gandal, J. Sisti, K. Klook, P. I. Ortinski, and V. Leitman, GABABmediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction, Transl Psychiatry, vol.2, p.142, 2012.

D. Manahan-vaughan, Long-term depression in freely moving rats is dependent upon strain variation, induction protocol and behavioral state, Cerebral Cortex, vol.10, pp.482-487, 2000.

N. Kemp and Z. I. Bashir, Induction of LTD in the adult hippocampus by the synaptic activation of AMPA/kainate and metabotropic glutamate receptors, Neuropharmacology, vol.38, pp.495-504, 1999.